These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 11545595)
1. Solution structure and dynamics of yeast elongin C in complex with a von Hippel-Lindau peptide. Botuyan MV; Mer G; Yi GS; Koth CM; Case DA; Edwards AM; Chazin WJ; Arrowsmith CH J Mol Biol; 2001 Sep; 312(1):177-86. PubMed ID: 11545595 [TBL] [Abstract][Full Text] [Related]
2. Binding of elongin A or a von Hippel-Lindau peptide stabilizes the structure of yeast elongin C. Botuyan MV; Koth CM; Mer G; Chakrabartty A; Conaway JW; Conaway RC; Edwards AM; Arrowsmith CH; Chazin WJ Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9033-8. PubMed ID: 10430890 [TBL] [Abstract][Full Text] [Related]
3. Biophysical characterization of elongin C from Saccharomyces cerevisiae. Buchberger A; Howard MJ; Freund SM; Proctor M; Butler PJ; Fersht AR; Bycroft M Biochemistry; 2000 Sep; 39(36):11137-46. PubMed ID: 10998253 [TBL] [Abstract][Full Text] [Related]
4. Identification of elongin C sequences required for interaction with the von Hippel-Lindau tumor suppressor protein. Takagi Y; Pause A; Conaway RC; Conaway JW J Biol Chem; 1997 Oct; 272(43):27444-9. PubMed ID: 9341197 [TBL] [Abstract][Full Text] [Related]
5. Identification of Elongin C and Skp1 sequences that determine Cullin selection. Yan Q; Kamura T; Cai Y; Jin J; Ivan M; Mushegian A; Conaway RC; Conaway JW J Biol Chem; 2004 Oct; 279(41):43019-26. PubMed ID: 15280393 [TBL] [Abstract][Full Text] [Related]
6. Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein. Ohh M; Takagi Y; Aso T; Stebbins CE; Pavletich NP; Zbar B; Conaway RC; Conaway JW; Kaelin WG J Clin Invest; 1999 Dec; 104(11):1583-91. PubMed ID: 10587522 [TBL] [Abstract][Full Text] [Related]
7. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma. Clifford SC; Astuti D; Hooper L; Maxwell PH; Ratcliffe PJ; Maher ER Oncogene; 2001 Aug; 20(36):5067-74. PubMed ID: 11526493 [TBL] [Abstract][Full Text] [Related]
8. Studying interactions of four proteins in the yeast two-hybrid system: structural resemblance of the pVHL/elongin BC/hCUL-2 complex with the ubiquitin ligase complex SKP1/cullin/F-box protein. Pause A; Peterson B; Schaffar G; Stearman R; Klausner RD Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9533-8. PubMed ID: 10449727 [TBL] [Abstract][Full Text] [Related]
9. The inducible elongin A elongation activation domain: structure, function and interaction with the elongin BC complex. Aso T; Haque D; Barstead RJ; Conaway RC; Conaway JW EMBO J; 1996 Oct; 15(20):5557-66. PubMed ID: 8896449 [TBL] [Abstract][Full Text] [Related]
10. Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products. Schoenfeld AR; Davidowitz EJ; Burk RD Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8507-12. PubMed ID: 10900011 [TBL] [Abstract][Full Text] [Related]
11. The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Pause A; Lee S; Worrell RA; Chen DY; Burgess WH; Linehan WM; Klausner RD Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2156-61. PubMed ID: 9122164 [TBL] [Abstract][Full Text] [Related]
12. Identification of a novel protein (VBP-1) binding to the von Hippel-Lindau (VHL) tumor suppressor gene product. Tsuchiya H; Iseda T; Hino O Cancer Res; 1996 Jul; 56(13):2881-5. PubMed ID: 8674032 [TBL] [Abstract][Full Text] [Related]
13. A molecular basis for stabilization of the von Hippel-Lindau (VHL) tumor suppressor protein by components of the VHL ubiquitin ligase. Kamura T; Brower CS; Conaway RC; Conaway JW J Biol Chem; 2002 Aug; 277(33):30388-93. PubMed ID: 12048197 [TBL] [Abstract][Full Text] [Related]
14. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Stebbins CE; Kaelin WG; Pavletich NP Science; 1999 Apr; 284(5413):455-61. PubMed ID: 10205047 [TBL] [Abstract][Full Text] [Related]
15. Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Kamura T; Koepp DM; Conrad MN; Skowyra D; Moreland RJ; Iliopoulos O; Lane WS; Kaelin WG; Elledge SJ; Conaway RC; Harper JW; Conaway JW Science; 1999 Apr; 284(5414):657-61. PubMed ID: 10213691 [TBL] [Abstract][Full Text] [Related]
18. Mammalian mediator subunit mMED8 is an Elongin BC-interacting protein that can assemble with Cul2 and Rbx1 to reconstitute a ubiquitin ligase. Brower CS; Sato S; Tomomori-Sato C; Kamura T; Pause A; Stearman R; Klausner RD; Malik S; Lane WS; Sorokina I; Roeder RG; Conaway JW; Conaway RC Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10353-8. PubMed ID: 12149480 [TBL] [Abstract][Full Text] [Related]
19. Formation of the VHL-elongin BC tumor suppressor complex is mediated by the chaperonin TRiC. Feldman DE; Thulasiraman V; Ferreyra RG; Frydman J Mol Cell; 1999 Dec; 4(6):1051-61. PubMed ID: 10635329 [TBL] [Abstract][Full Text] [Related]